Antenatal and Postnatal Care Research Collective - Household Survey (ARCH)

NCT ID: NCT05154331

Last Updated: 2025-05-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

7500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-03-29

Study Completion Date

2026-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overarching goal of the ARCH Survey is to establish a prospective longitudinal pregnancy surveillance study in Lusaka, Zambia, to precisely characterize the pregnancy rate and outcomes of women of reproductive age prior to, during, and following pregnancy and to investigate the structural, sociodemographic, and clinical covariates that contribute to adverse outcomes in each reproductive epoch.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The overall purpose of this study is to better understand the health and well-being of women before and after they become pregnant and of their infants. This information will contribute to the understanding of the health needs of women and their children, which may help doctors provide mothers and children with better care in the future.

Participants in this study will be visited four times a year (every 3 months) for up to three years in total. At each visit a review of their medical records, a brief physical exam and urine pregnancy test will be conducted. Participants will also answer survey questions and self-collect vaginal swabs for future testing. We will enroll up to 5,500 women and include any infants that are born to them during their study participation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Maternal Health Pregnancy Outcomes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Women of reproductive age

Women 15-49 years of age

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Women of reproductive age eligibility criteria


* Verbal consent obtained from head-of-household
* 15-49 years of age and a member of household in the catchment area
* Willing and able to provide written informed consent or assent with next-of-kin consent
* Willing to undergo study procedures

Exclusion Criteria

Any other condition (social or medical) that, in the opinion of the study staff, would make participation unsafe or complicate data interpretation. Study staff may note physical, psychological, or social conditions not explicitly stated in the eligibility criteria that could make some women poor candidates for study participation.
Minimum Eligible Age

1 Day

Maximum Eligible Age

49 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bill and Melinda Gates Foundation

OTHER

Sponsor Role collaborator

University of Zambia

OTHER

Sponsor Role collaborator

University of North Carolina, Chapel Hill

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jeff Stringer

Role: PRINCIPAL_INVESTIGATOR

University of North Carolina, Chapel Hill

Wilbroad Mutale, MD

Role: PRINCIPAL_INVESTIGATOR

University of Zambia (UNZA) Lusaka, Zambia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Zambia

Lusaka, , Zambia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Zambia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mutale Sampa

Role: CONTACT

+260977287091

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mutale Sampa

Role: primary

+260977287091

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

21-1370

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Uganda Birth Cohort Study
NCT04233944 TERMINATED